Outcomes Fund

Phaidra, Inc. is a Seattle-based company established in 2019 that specializes in designing and developing artificial intelligence solutions for industrial sectors in the United States. The company focuses on providing AI and machine learning technologies aimed at enhancing performance in large-scale facilities. Phaidra's offerings include a virtual plant operator service that utilizes closed-loop AI control to empower operations teams in mission-critical environments. By analyzing extensive sensor data, Phaidra creates intelligent agents that automatically optimize and manage complex industrial processes. This innovative approach helps clients improve energy efficiency, increase safety and stability, and maximize operational yield, contributing to greater sustainability in their operations.

Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.

nFlux AI is a developer of an artificial general intelligence platform focused on enhancing human capabilities through advanced technology. The company specializes in computer vision operations, providing intelligent video analytics that automate the extraction of contextual insights from unstructured data within video footage. This innovative approach allows clients to leverage proprietary machine comprehension services, enabling a deeper understanding of their data. nFlux's first significant collaboration was with NASA, where the company was tasked with creating a cognitive architecture to support deep space missions, allowing intelligent systems to assist astronauts autonomously when communication with Earth is not feasible. The company's vision is to advance intelligence in ways that positively impact humanity, supported by investments from prominent organizations and venture capital firms.

ECFX, Inc. is a software development company based in Venice, California, that focuses on automating processes within the legal industry. Founded in 2019, ECFX has created ECFX Notice, an enterprise notice management system that enhances the workflow for electronic court notices. This platform automates the downloading, profiling, storing, and distribution of court documents from both Federal and State courts, allowing law firms to efficiently manage electronic filings. ECFX Notice facilitates the automatic organization of documents according to firm-specific naming conventions and offers customizable options for email notifications, ensuring that all relevant team members receive documents in their preferred formats. Additionally, the platform features an Analytics Dashboard that enables administrators to monitor electronic court filing activities, thereby improving operational efficiency and reducing the risks associated with manual data entry.

Neyborly is a commercial real estate company focused on transforming under-utilized urban spaces into vibrant community hubs for events, meetings, and pop-up activities. By revitalizing vacant properties, Neyborly provides customizable and affordable rental spaces that cater to a variety of needs, such as birthday parties, corporate meetings, and art shows. The company leverages design, data, and exceptional customer service to create unique environments that foster connection and creativity. Committed to democratizing access to real estate, Neyborly aims to reshape how individuals and organizations utilize spaces in their neighborhoods, ultimately bringing people together to celebrate and inspire within their communities.

Activeconnect works on all types of devices and operating systems for every transaction including iOS, Android, Windows, and Mac OS. We provide a well-documented API and everything needed to build applications that have frictionless step-up authentication without needing passwords. Activeconnect’s technology powers authentication for any platform, web application, mobile application, software, and just about everything that needs user authentication and secure transactions. We help our Clients Avoid Account Takeover (ATO), reduce fraud and enable frictionless security steps to make any transaction secure, easy, cost-effective, and instantly scalable.

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing small molecules aimed at restoring neuronal health and halting neurodegeneration. The company's lead product candidate, ATH-1017, is a small molecule designed to penetrate the blood-brain barrier and acts as a hepatocyte growth factor/MET activator, currently undergoing various clinical trials for treating Alzheimer’s and Parkinson’s diseases. In addition to ATH-1017, Athira is developing several other candidates, including ATH-1019 for depression and ATH-1018 for peripheral neuropathy, which are in the preclinical stage. Founded in 2011 and initially known as M3 Biotechnology, Athira Pharma changed its name in April 2019 to reflect its mission of advancing innovative therapies to improve the lives of individuals affected by brain disorders.